We derive the nonequilibrium real-time evolution of an O(N)-invariant scalar quantum field theory in the presence of a nonvanishing expectation value of the quantum field. Using a systematic 1/N expansion of the 2PI effective action to next-to-leading order, we obtain nonperturbative evolution equations which include scattering and memory effects. The equivalence of the direct method, which requires the resummation of an infinite number of skeleton diagrams, with the auxiliary-field formalism, which involves only one diagram at next-to-leading order, is shown.
Nonperturbative approximation schemes based on two-particle irreducible (2PI) effective actions provide an important means for our current understanding of (non-)equilibrium quantum field theory. A remarkable property is their renormalizability, since these approximations involve selective summations to infinite perturbative orders. In this paper we show how to renormalize all n-point functions of the theory, which are given by derivatives of the 2PI-resummed effective action Γ[φ] for scalar fields φ. This provides a complete description in terms of the generating functional for renormalized proper vertices, which extends previous prescriptions in the literature on the renormalization for 2PI effective actions. The importance of the 2PI-resummed generating functional for proper vertices stems from the fact that the latter respect all symmetry properties of the theory and, in particular, Goldstone's theorem in the phase with spontaneous symmetry breaking. This is important in view of the application of these techniques to gauge theories, where Ward identities play a crucial role. *
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.